TAG / BIG PHARMA

With millions of Americans prescribed GLP-1 drugs, researchers warn of catastrophic risks ignored by Big Pharma.

Drug regulatory agencies in Germany and Australia have added warnings that atomoxetine can trigger violent or suicidal thoughts—sparking urgent concern over its long‑term use in children and adults.

A 10‑member FDA panel met amid mounting evidence that antidepressants may impair fetal brain development.

Evidence suggests drugmakers manipulated trials and government failed to respond while patients live with permanent loss of sexual function.

The Department of Veterans Affairs partners with Big Pharma to fuel “treatment” that triggers the very suicides it claims to prevent.

Purdue prepares to pay up, leaving unanswered questions about justice, accountability and how hundreds of thousands of lives might have been saved if regulators had acted sooner.

How pharmaceutical reps use charm, freebies and seduction to shape what your doctor prescribes—and why the cozy relationship may be costing you more than you think.

The state’s groundbreaking law demands public accountability and total transparency on psychiatric drugs tied to mass murder.

From cozy relationships to blockbuster approvals, a new FDA policy promises transparency after decades of industry entanglement. But is it too little, too late?

As an FDA executive, Cavazzoni handed Pfizer, her former employer, a record-setting number of approved drugs in one year. And now she’s back. There’s a reason they call it the “revolving door.”